No microvascular complications (n = 111) | 1 microvascular complications (n = 75) | 2–3 microvascular complications (n = 36) | p | |
---|---|---|---|---|
Echocardiography | ||||
LVEF (%) | 56 ± 5 | 54 ± 6 | 55 ± 5 | ns |
GLS (%) | − 16.4 ± 2.5 | − 16.0 ± 2.5 | − 14.9 ± 2.8 | 0.01 |
LAVI (ml/m2) | 22 ± 7 | 23 ± 7 | 21 ± 5 | ns |
LVMI (g/m2) | 71 ± 23 | 77 ± 21 | 71 ± 19 | ns |
e’ (cm/sec) | 0.09 ± 0.02 | 0.09 ± 0.05 | 0.08 ± 0.02 | 0.03 |
IVRT (msec) | 82 ± 20 | 84 ± 17 | 83 ± 17 | ns |
E/e’ | 9.2 ± 2.9 | 9.7 ± 3.1 | 10.0 ± 2.7 | ns |
E/A | 1.1 ± 0.3 | 1.0 ± 0.3 | 0.9 ± 0.3 | ns |
DCT (msec) | 221 ± 56 | 221 ± 53 | 209 ± 44 | ns |
Computed tomography | ||||
CAC [IQR] | 39 [0–239] | 22 [0–180] | 130 [30–720] | ns* |
PB (%) | 20 ± 17 | 22 ± 16 | 27 ± 18 | ns |
PB LAD/LM (%) | 36 ± 11 | 35 ± 9 | 40 ± 11 | ns |
PB RCA (%) | 26 ± 8 | 27 ± 10 | 30 ± 11 | ns |
PB CX (%) | 33 ± 12 | 31 ± 11 | 37 ± 13 | ns |